Dictionary

allow_url_fopen is ENABLED Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
Clinical trial: Hemophilia B, (NCT06611436) - CRISPR Medicine - CRISPR Medicine News
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Haemophilia gene therapy patients thriving over a decade after treatment | UCL News - UCL - UCL - London's Global University
Haemophilia B gene therapy safe, effective for long-term: Study - Suryaa
Haemophilia B gene therapy safe, effective for long-term: Study - deshsewak.org
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial - The Lancet
Get easily bruised? It may be due to haemophilia B - Healthshots
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
Gene therapy offers long-term relief for Haemophilia B: Study - Daijiworld
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Hemgenix shows efficacy among haemophilia B patients - PharmaTimes
A Reality Check of Hemophilia Care: What a Real-World Study Says About the Unmet Needs of People With Hemophilia A or B - Managed Healthcare Executive
Gene therapy: a powerful tool for hemophilia B? - Labiotech.eu
Gene therapy frees hemophilia patient from constant worry, needles - Harvard Gazette
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
rFIXFc Safe and Effective in Treating Hemophilia B - Hematology Advisor
NICE recommends Pfizer once-weekly treatment for haemophilia B on NHS - European Pharmaceutical Manufacturer
Hemophilia B Market Size to Reach USD 24.7 Billion by 2035, Impelled by Advancements in Gene Therapy - BioSpace
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapy - Frontiers
Multiyear Follow-up Study Shows Positive Results for Hemophilia B Gene Therapy - Managed Healthcare Executive
Six biotech companies leading the charge in hemophilia treatment - Labiotech.eu
First hemophilia B patients in Denmark treated with Hemgenix –... - Hemophilia News Today
Pfizer to Discontinue Its Hemophilia B Gene Therapy - MedPage Today
Concizumab reduces bleeding in patients without inhibitors - Hemophilia News Today
Pfizer Jettisons FDA-Approved Hemophilia B Gene Therapy Beqvez - CGTLive®
FDA Approves First Prophylactic Therapy for Hemophilia A or B With or Without Inhibitors - Managed Healthcare Executive
VisualAbstract: Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B is Superior to Prophylaxis - 2 Minute Medicine
CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix - PMLiVE
Pfizer stops selling hemophilia gene therapy, citing weak demand - BioPharma Dive
Phase 1/2 clinical trial of BE-101 now enrolling hemophilia B patients - Hemophilia News Today
Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval - Fierce Biotech
Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio - Fierce Pharma
Pfizer pulls the plug on haemophilia gene therapy - FirstWord Pharma
European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors - Business Wire
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B - PR Newswire
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Today
Children's Hospital of Philadelphia Researchers Find Gene Therapy Shows Long-Term Benefits for Hemophilia B Patients - PR Newswire
Be Bio secures $92m to advance BCM treatments - Pharmaceutical Technology
Sanofi, Alnylam Win First RNAi Approval for Hemophilia A and B - BioSpace
Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial - Pharmaceutical Technology
News and Expert Insights in Hemophilia Gene Therapy for Bleeding Disorders Awareness Month 2025 - CGTLive®
A New Era of Hemophilia Care: Perspectives from Denmark - Global Biotechnology Company
Pfizer’s bet on gene therapies in haemophilia has been a bust - Pharmaceutical Technology
FDA Approves Pfizer's Hympavzi for Hemophilia A, B - Medscape
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A - insights.citeline.com
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B - Wiley Online Library
Clinical trial: Hemophilia B, (NCT06379789) - CRISPR Medicine - CRISPR Medicine News
Pfizer shelves haemophilia gene therapy Beqvez amid low demand - Pharmaceutical Technology
Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B - PMLiVE
Sanofi’s Qfitlia granted FDA approval to treat haemophilia A or B - PMLiVE
(PDF) Gene therapy for haemophilia: a very modern success story - researchgate.net
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patients - Pharmaceutical Technology
Sanofi's versatile Qfitlia scores FDA nod to enter crowded hemophilia market - Fierce Pharma
MHRA nod for Hympavzi for hemophilia A or B - The Pharma Letter
Haemophilia B: The Rare Disorder That Might Be Hiding Behind Your Bruises - OnlyMyHealth
As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay - Fierce Pharma
Pfizer receives EU haemophilia B gene therapy approval - European Pharmaceutical Review
First subcutaneous treatment for severe Haemophilia B recommended - National Health Executive
FDA approves Pfizer’s HYMPAVZI to treat haemophilia - Pharmaceutical Technology
Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B - GOV.UK
Gene Therapy in Hemophilia: High Hopes and Costs, Low Uptake - Medscape
Haemophilia B: My £2.6m blood has 'cured' my haemophilia - BBC
Hympavzi Recommended for Approval in Europe for Severe Hemophilia A and B - Medscape
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark - Pharmafile
Alhemo (concizumab-mtci) for hemophilia - Hemophilia News Today
Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi-criteria decision analysis - Wiley Online Library
Development of SerpinPC as treatment for hemophilia halted by Centessa - Hemophilia News Today
New Hemophilia Treatment Approved by FDA - Technology Networks
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors FDA Approved - Managed Healthcare Executive
New Hemophilia Drug Helps Prevent Bleeding Episodes - WebMD
ASH 2024 discussions shine spotlight on advances in haemophilia treatments - Pharmaceutical Technology
EU approves Pfizer's haemophilia therapy Hympavzi - FirstWord Pharma
Pfizer's haemophilia B gene therapy gets EU green light - pharmaphorum
Pfizer’s Hympavzi receives EC approval to treat haemophilia A and B patients - PMLiVE
UK: population with hemophilia/bleeding disorders 2023 - Statista
Qfitlia approved by FDA to treat haemophilia A or B - Pharmafile
Pfizer ducks out of Sangamo haemophilia A alliance - pharmaphorum
Pfizer quickly expands its hemophilia B gene therapy's reach with EU approval - Fierce Pharma
Germany will reimburse haemophilia gene therapy Hemgenix - pharmaphorum
A 'transformative' gene therapy for haemophilia B - The Week
Hemophilia B Pipeline Drugs 2025: Clinical Trials, EMA, PDMA, - openPR.com
Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights - GlobeNewswire
An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India - Cureus
Novo's once-daily haemophilia therapy scores FDA nod on second try - FirstWord Pharma
New gene therapy for hemophilia used for the first time in Austria - MedUni Wien
Novo Nordisk wins hard-fought FDA approval for once-daily hemophilia med Alhemo - Fierce Pharma
Pfizer rounds out haemophilia portfolio with FDA approval - pharmaphorum
Pfizer’s Hympavzi Wins FDA Approval to Treat Hemophilia (PFE) - Bloomberg.com
Pfizer infringed haemophilia B gene therapy patent - Progress Educational Trust
NICE recommends CSL Behring’s haemophilia B gene therapy Hemgenix - PMLiVE
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
Pfizer gets EC approval for Hympavzi to treat Haemophilia A/B - World Pharmaceutical Frontiers
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ahemophilia b,   haemophiilia b,   aemophilia b,   haemophiliaa b,   haemopihlia b,   haemophilua b,   hae,ophilia b,   haemophliia b,   haemophili b,   haemophilia v,   haeemophilia b,   haemophlia b,   haemiphilia b,   haemophila b,   haemoophilia b,   haemophiliab,   hameophilia b,   haemophilia ,   haemophilai b,   haemo[hilia b,   haemoohilia b,   haemophilia n,   haemophillia b,   haemophhilia b,   haemopholia b,   haemophikia b,   jaemophilia b,   haeophilia b,   haemopphilia b,   heamophilia b,   hawmophilia b,   gaemophilia b,   haeomphilia b,   haemophiila b,   haempphilia b,   hhaemophilia b,   haemopjilia b,   haemohpilia b,   haemophilis b,   haemohilia b,   haemophili ab,   haemophilia b,   haemophiloa b,   haemmophilia b,   haemophi;ia b,   hamophilia b,   haemophilia bb,   haemopgilia b,   harmophilia b,   haemophiliab ,   hemophilia b,   hsemophilia b,   haenophilia b,   haemophiliia b,   haempohilia b,   haaemophilia b,   haemopilia b,   haemphilia b,   haemophulia b,   haemophiia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z